| Target Professions: | DO, MD, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Neurology |
| Credits Available: | 4.00 hours of AMA PRA Category 1 Credit™, MOC Points Available |
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a progressive immune-mediated disorder of the peripheral nerves attributed to demyelination and impairment of signal conduction in motor and/or sensory nerves. Symptoms include loss of strength and sensation typically causing symmetrical, proximal, and distal weakness. Disease progression is variable, with many patients experiencing chronic patterns of relapse and remission. This proposed educational initiative establishes impactful small group interactions among highly qualified neurology providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with CIDP. This program will include discussions with experts and peers who can share knowledge, real world experiences, strategies, challenges, and success stories.
Answer the questions to gauge your current knowledge of CIDP: diagnosis and workup, evidence for and use of subcutaneous therapies, and use of corticosteroids.
This module reviews the clinical presentation, differential, and workup of CIDP, including separation from GBS and from mimics such as MMN and CIDP variants.
This module will focus on the diagnosis and treatment of chronic immune-mediated polyneuropathies, with a focus on chronic inflammatory demyelinating polyneuropathy (CIDP).
In this module, we will discuss the judicious and appropriate use of corticosteroids in CIDP.
After completing the modules, answer these questions to assess your mastery of CIDP: diagnosis and workup, evidence for and use of subcutaneous therapies, and use of corticosteroids.
Richard is a 71-year-old man was brought to the emergency department by ambulance after falling during an appointment with his family doctor. He complained of 9 weeks of progressive leg weakness, intermittent lancinating lower back pain, and had fallen tw
You will develop an action plan to improve the care of your patients with CIDP.
This Live Group Discussion will review a case involving a 58-year-old CIDP woman with diabetes, and a 65-year-old man needing medication changes. We will also address any questions or comments you may have regarding the self‑study modules and baseline/final assessments.